Abstract
Paclitaxel (PTX) and organophilic iron oxide nanocrystals of 7 nm average size were co-encapsulated in the oily core of poly(lactide)-poly(ethyleneglycol) (PLA-PEG) nanocapsules in order to develop magnetically responsive nanocarriers of PTX. The nanocapsules were prepared by a solvent displacement technique and exhibited satisfactory drug and iron oxide loading efficiency, high colloidal stability, and sustained drug release properties. Drug release also proved responsive to an alternating magnetic field. Magnetophoresis experiments showed that the magnetic responsiveness of the nanocapsules depended on their SPION content. The PTX-loaded nanocapsules exhibited comparable to free PTX cytotoxicity against the A549 lung cancer cell line at 24 h of incubation but higher cytotoxicity than free drug at 48 h of incubation. The conjugation of a cysteine-modified TAT peptide (HCys-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2) on the surface of the nanocapsules resulted to highly increased uptake of nanocapsules by cancer cells, as well as to profound improvement of their cytotoxicity against the cancer cells. The results obtained justify further investigation of the prospects of these multifunctional PLA-PEG nanocapsules as a targeted delivery system of paclitaxel.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59:225–49.
Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci. 2003;94:15–21.
Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer. 2006;6:688–701.
Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2010;62:284–304.
Shokeen M, Pressly ED, Hagooly A, Zheleznyak A, Ramos N, Fiamengo AL, et al. Evaluation of multivalent, multi-functional polymeric nanoparticles for imaging applications. ACS Nano. 2011;5:738–47.
Maeda H, Bharate GY, Daruwala J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm. 2009;71:409–19.
Lübbe AS, Alexiou C, Bergemann CJ. Clinical applications of magnetic drug targeting. Surg Res. 2001;95:200–6.
Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology. 2001;218:27–38.
Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348:2491–9.
Enochs WS, Harsh G, Hochberg F, Weissleder R. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent. J Magn Res Imag. 1999;9:228–32.
Müller S. Magnetic fluid hyperthermia therapy for malignant brain tumors—an ethical discussion. Nanomed: Nanotech Biol Med. 2009;5:387–93.
Van Landeghem FKH, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow U, Scholz R, et al. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials. 2009;30:52–7.
Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol/Hematol. 2002;43:33–56.
Shakeri-Zadeh A, Khoee S, Shiran MB, Sharifi AM, Khoei S. Synergistic effects of magnetic drug targeting using a newly developed nanocapsule and tumor irradiation by ultrasound on CT26 tumors in BALB/c mice. J Mater Chem B. 2015;3:1879–87.
Elumalai R, Patil S, Maliyakkal N, Rangarajan A, Kondaiah P, Raichur AM. Protamine-carboxymethyl cellulose magnetic nanocapsules for enhanced delivery of anticancer drugs against drug resistant cancers. Nanomedicine. 2015;11:969–81.
Crown J, O’Leary M. The taxanes: an update. Lancet. 2000;355:1176–8.
Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med. 1995;332:1004–14.
Finley RS, Rowinsky EK. Patient care issues: the management of paclitaxel-related toxicities. Ann Pharmacother. 1994;28:S27–30.
Ma P, Mumper RJ. Paclitaxel nano-delivery systems: a comprehensive review. Nanomed Nanotech. 2013;J4:164.
Green MR, Manikhas GM, Orlov S, Afanasyev B, Makhson AM, Bhar P, et al. Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann Oncol. 2006;17:1263–8.
Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, et al. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res. 2002;8:1038–44.
Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 2006;66:6732–40.
Hatakeyama H, Akita H, Ishida E, Hashimoto K, Kobayashi H, Aoki T, et al. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes. Int J Pharm. 2007;342:194–200.
Torchilin VP. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. Biopolymers. 2008;90:604–10.
Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano. 2008;2:889–96.
Bakandritsos A, Mattheolabakis G, Zboril R, Bouropoulos N, Fatouros D, Tucek J, et al. Preparation, stability and cytocompatibility of magnetic/PLA-PEG hybrids. Nanoscale. 2010;2:564–72.
Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385:113–42.
Mykhaylyk O, Antequera YS, Vlaskou D, Plank C. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc. 2007;2:2391–411.
Bongio M, van den Beucken JJP, Nejadnik MR, Leeuwenburgh SCG, Kinard LA, Kasper FK, et al. Biomimetic modification of synthetic hydrogels by incorporation of adhesive peptides and calcium phosphate nanoparticles: in vitro evaluation of cell behavior. Eur Cells Mater. 2011;22:359–76.
Dengler WA, Schulte J, Berger DP, Mertelsmann R, Fiebig HH. Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anti-Cancer Drugs. 1995;6:522–32.
Chazotte B. Labeling nuclear DNA using DAPI. In: Yuste R, editor. CSHL Press: Cold Spring Harbor. 2010. p. 80–82.
Zoppellaro G, Kolokithas-Ntoukas A, Polakova K, Tucek J, Zboril RG, Loudos G. Theranostics of epitaxially condensed colloidal nanocrystal clusters, through a soft biomineralization route. Chem Mater. 2014;26:2062–74.
Bakandritsos A, Papagiannopoulos A, Anagnostou EN, Avgoustakis K, Zboril R, Pispas S, et al. Merging high doxorubicin loading with pronounced magnetic response and bio‐repellent properties in hybrid drug nanocarriers. Small. 2012;8:2381–93.
Avgoustakis K, Nixon JR. Biodegradable controlled release tablets: 1. Preparative variables affecting the properties of poly(lactide-co-glycolide) copolymer as matrix forming material. Int J Pharm. 1991;79:77–85.
Fortin JP, Wilhelm C, Servais J, Menager C, Bacri CJ, Gazeau F. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J Am Chem Soc. 2007;129:2628–35.
Oliveira H, Pérez-Andrés E, Thevenot J, Sandre O, Berra E, Lecommandoux S. Magnetic field triggered drug release from polymersomes for cancer therapeutics. J Contrl Rel. 2013;169:165–70.
Peiris PM, Bauer L, Toy R, Tran E, Pansky J, Doolittle E, et al. Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. ACS Nano. 2012;6:4157.
Jun YW, Lee JH, Cheon J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angewandte Chemie - Int Ed. 2008;47:5122–35.
Lee JH, Chen KJ, Noh SH, Garcia MA, Wang H, Lin WY, et al. On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles. Angewandte Chemie - Int Ed. 2013;52:4384–8.
Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi JS, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006;6:2427–30.
Ren J, Hong H, Ren T, Teng X. Preparation and characterization of magnetic PLA-PEG composite nanoparticles for drug targeting. React Funct Polym. 2006;66:944–51.
Jun Y, Seo J, Cheon J. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc Chem Res. 2008;41:179–89.
Madani M, Sharifi Sanjani N, Faridi MR. Magnetic polystyrene nanocapsules with core–shell morphology obtained by emulsifier free miniemulsion polymerization. Polym Sci Ser A. 2011;53:143–8.
Mohsen Ashjari M, Khoee S, Reza MA. A multiple emulsion method for loading 5-fluorouracil into a magnetite-loaded nanocapsule: a physicochemical investigation. Polym Int. 2012;61:850–9.
Vivès E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997;272:16010–7.
Acknowledgments
This research was supported by the European Union (European Social Fund—ESF) and Greek national funds through the Operational Program “Education and Lifelong Learning” of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thales - Investing in knowledge society through the European Social Fund.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 593 kb)
Rights and permissions
About this article
Cite this article
Koutsiouki, K., Angelopoulou, A., Ioannou, E. et al. TAT Peptide-Conjugated Magnetic PLA-PEG Nanocapsules for the Targeted Delivery of Paclitaxel: In Vitro and Cell Studies. AAPS PharmSciTech 18, 769–781 (2017). https://doi.org/10.1208/s12249-016-0560-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-016-0560-9